Treat tardive dyskinesia and Huntington’s disease chorea

to help further your patients’ clinical goals

AUSTEDO (deutetrabenazine) tablets is the first and only medication approved to treat both TD in adults and HD chorea.1

demonstrated efficacy

Flexible dosing to help meet the individual needs of your patients1

REVIEW FLEXIBLE DOSING
Learn more about why AUSTEDO may be right for the diverse treatment needs of your patients
REGISTER FOR UPDATES
Get to know Teva’s Shared Solutions®

Your partner for patient support.
Call Teva’s Shared Solutions® at 1-800-887-8100

Learn More

You are about to leave this site

You are about to leave AUSTEDO.com and enter a website operated by a third party. Teva is not responsible for and does not control the content contained on this third-party website linked to AUSTEDO.com.

Are you a healthcare professional?

The information on this site is intended for healthcare professionals in the United States. Are you a healthcare professional in the United States?

Reference: 1. AUSTEDO® (deutetrabenazine) tablets current Prescribing Information Parsippany, NJ. Teva Neuroscience, Inc.